[Studies of brain stem function in infants with apnea syndrome using acoustically evoked brain stem potentials and heart rate variability].
Twenty-four infants aged between 6 days and 7 months and 2 infants (16 m and 3 y) were subjects of combined brain-stem auditory evoked potential and heart rate variability measurements. Ten infants had a sleep apnea syndrome and one a Near miss sudden infant death syndrome; thirteen infants formed the control group. Seventeen of the twenty-six infants had normal, age-depended brain stem potentials. All infants of the apnea syndrome-group, which had no therapy, had increased I to V interpeak latencies outside of the one-sigma level, the six infants treated with aminophylline were within the normal range. Heart rate variability measurements revealed the following mean +/- standard deviation of the control group: 4.5% +/- 1.5%; of the apnea syndrome-group without therapy: 5.4% +/- 2.0%.
D000628:Aminophylline / Q000627:therapeutic use; D001933:Brain Stem / Q000503:physiopathology*; D002657:Child Development / Q000187:drug effects; D002675:Child, Preschool; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007223:Infant; D012306:Risk; D012891:Sleep Apnea Syndromes / Q000503:physiopathology* / Q000517:prevention & control; D013398:Sudden Infant Death / Q000503:physiopathology* / Q000517:prevention & control
D000628:Aminophylline
Hirnstammfunktionsuntersuchungen an Säuglingen mit Apnoe-Syndrom unter Verwendung akustisch evozierter Hirnstammpotentiale und der Herzratenvariabilität.